Your browser doesn't support javascript.
loading
Enrollment Barriers for Molecular Targeted Trials.
Paydary, Koosha; DeLuca, Alli; Aggarwal, Rahul; Wall, Lauren; Stadler, Walter M.
Affiliation
  • Paydary K; University of Chicago Medicine, Comprehensive Cancer Center, Chicago, Illinois.
  • DeLuca A; Tempus Labs, Chicago, Illinois.
  • Aggarwal R; University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco.
  • Wall L; University of Chicago Medicine, Comprehensive Cancer Center, Chicago, Illinois.
  • Stadler WM; University of Chicago Medicine, Comprehensive Cancer Center, Chicago, Illinois.
JAMA Oncol ; 9(6): 863-864, 2023 06 01.
Article in En | MEDLINE | ID: mdl-37022722
This quality improvement study examines the difficulties of patient accrual among patients with cancer and SETD2 variants.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Molecular Targeted Therapy / Neoplasms Limits: Humans Language: En Journal: JAMA Oncol Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Molecular Targeted Therapy / Neoplasms Limits: Humans Language: En Journal: JAMA Oncol Year: 2023 Document type: Article